vs

Side-by-side financial comparison of Dexcom (DXCM) and F5, Inc. (FFIV). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $822.5M, roughly 1.5× F5, Inc.). F5, Inc. runs the higher net margin — 21.9% vs 21.2%, a 0.7% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 7.3%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 9.9%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

F5, Inc. is an American technology company specializing in application security, multi-cloud management, online fraud prevention, application delivery networking (ADN), application availability and performance, and network security, access, and authorization.

DXCM vs FFIV — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.5× larger
DXCM
$1.3B
$822.5M
FFIV
Growing faster (revenue YoY)
DXCM
DXCM
+14.3% gap
DXCM
21.6%
7.3%
FFIV
Higher net margin
FFIV
FFIV
0.7% more per $
FFIV
21.9%
21.2%
DXCM
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
9.9%
FFIV

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
FFIV
FFIV
Revenue
$1.3B
$822.5M
Net Profit
$267.3M
$180.1M
Gross Margin
62.9%
81.5%
Operating Margin
25.6%
26.0%
Net Margin
21.2%
21.9%
Revenue YoY
21.6%
7.3%
Net Profit YoY
153.6%
8.2%
EPS (diluted)
$0.67
$3.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
FFIV
FFIV
Q1 26
$1.3B
Q4 25
$1.3B
$822.5M
Q3 25
$1.2B
$810.1M
Q2 25
$1.2B
$780.4M
Q1 25
$1.0B
$731.1M
Q4 24
$1.1B
$766.5M
Q3 24
$994.2M
$746.7M
Q2 24
$1.0B
$695.5M
Net Profit
DXCM
DXCM
FFIV
FFIV
Q1 26
$267.3M
Q4 25
$267.3M
$180.1M
Q3 25
$283.8M
$190.5M
Q2 25
$179.8M
$189.9M
Q1 25
$105.4M
$145.5M
Q4 24
$151.7M
$166.4M
Q3 24
$134.6M
$165.3M
Q2 24
$143.5M
$144.1M
Gross Margin
DXCM
DXCM
FFIV
FFIV
Q1 26
62.9%
Q4 25
62.9%
81.5%
Q3 25
60.5%
82.2%
Q2 25
59.5%
81.0%
Q1 25
56.9%
80.7%
Q4 24
58.9%
81.7%
Q3 24
59.7%
80.8%
Q2 24
62.4%
80.4%
Operating Margin
DXCM
DXCM
FFIV
FFIV
Q1 26
25.6%
Q4 25
25.6%
26.0%
Q3 25
20.1%
25.4%
Q2 25
18.4%
25.2%
Q1 25
12.9%
21.7%
Q4 24
17.0%
26.8%
Q3 24
15.3%
25.6%
Q2 24
15.7%
23.4%
Net Margin
DXCM
DXCM
FFIV
FFIV
Q1 26
21.2%
Q4 25
21.2%
21.9%
Q3 25
23.5%
23.5%
Q2 25
15.5%
24.3%
Q1 25
10.2%
19.9%
Q4 24
13.6%
21.7%
Q3 24
13.5%
22.1%
Q2 24
14.3%
20.7%
EPS (diluted)
DXCM
DXCM
FFIV
FFIV
Q1 26
$0.67
Q4 25
$0.67
$3.10
Q3 25
$0.70
$3.25
Q2 25
$0.45
$3.25
Q1 25
$0.27
$2.48
Q4 24
$0.37
$2.82
Q3 24
$0.34
$2.79
Q2 24
$0.35
$2.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
FFIV
FFIV
Cash + ST InvestmentsLiquidity on hand
$917.7M
$1.2B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$3.5B
Total Assets
$6.3B
$6.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
FFIV
FFIV
Q1 26
$917.7M
Q4 25
$917.7M
$1.2B
Q3 25
$1.8B
$1.3B
Q2 25
$1.2B
$1.4B
Q1 25
$904.9M
$1.3B
Q4 24
$606.1M
$1.2B
Q3 24
$621.2M
$1.1B
Q2 24
$939.2M
$935.6M
Stockholders' Equity
DXCM
DXCM
FFIV
FFIV
Q1 26
$2.7B
Q4 25
$2.7B
$3.5B
Q3 25
$2.7B
$3.6B
Q2 25
$2.6B
$3.5B
Q1 25
$2.3B
$3.3B
Q4 24
$2.1B
$3.2B
Q3 24
$2.0B
$3.1B
Q2 24
$2.4B
$3.0B
Total Assets
DXCM
DXCM
FFIV
FFIV
Q1 26
$6.3B
Q4 25
$6.3B
$6.3B
Q3 25
$7.5B
$6.3B
Q2 25
$7.3B
$6.1B
Q1 25
$6.8B
$5.9B
Q4 24
$6.5B
$5.9B
Q3 24
$6.4B
$5.6B
Q2 24
$6.8B
$5.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
FFIV
FFIV
Operating Cash FlowLast quarter
$159.2M
Free Cash FlowOCF − Capex
$149.5M
FCF MarginFCF / Revenue
18.2%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$861.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
FFIV
FFIV
Q1 26
Q4 25
$294.0M
$159.2M
Q3 25
$659.9M
$208.1M
Q2 25
$303.0M
$282.2M
Q1 25
$183.8M
$256.6M
Q4 24
$301.4M
$202.8M
Q3 24
$199.5M
$246.5M
Q2 24
$279.4M
$159.0M
Free Cash Flow
DXCM
DXCM
FFIV
FFIV
Q1 26
Q4 25
$192.1M
$149.5M
Q3 25
$579.4M
$191.9M
Q2 25
$208.9M
$273.7M
Q1 25
$96.8M
$246.1M
Q4 24
$176.8M
$194.7M
Q3 24
$88.3M
$240.4M
Q2 24
$213.3M
$153.1M
FCF Margin
DXCM
DXCM
FFIV
FFIV
Q1 26
Q4 25
15.3%
18.2%
Q3 25
47.9%
23.7%
Q2 25
18.1%
35.1%
Q1 25
9.3%
33.7%
Q4 24
15.9%
25.4%
Q3 24
8.9%
32.2%
Q2 24
21.2%
22.0%
Capex Intensity
DXCM
DXCM
FFIV
FFIV
Q1 26
Q4 25
8.1%
1.2%
Q3 25
6.7%
2.0%
Q2 25
8.1%
1.1%
Q1 25
8.4%
1.4%
Q4 24
11.2%
1.1%
Q3 24
11.2%
0.8%
Q2 24
6.6%
0.8%
Cash Conversion
DXCM
DXCM
FFIV
FFIV
Q1 26
Q4 25
1.10×
0.88×
Q3 25
2.33×
1.09×
Q2 25
1.69×
1.49×
Q1 25
1.74×
1.76×
Q4 24
1.99×
1.22×
Q3 24
1.48×
1.49×
Q2 24
1.95×
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

FFIV
FFIV

Services$412.2M50%
Products$410.3M50%

Related Comparisons